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A direct role for SNX9 in the biogenesis of filopodia
Iris K. Jarsch1*, Jonathan R. Gadsby1*, Annalisa Nuccitelli2, Julia Mason1, Hanae Shimo1, Ludovic Pilloux3, Bishara Marzook1, Claire M. Mulvey1,
Ulrich Dobramysl1, Charles R. Bradshaw1, Kathryn S. Lilley4, Richard D. Hayward3, Tristan J. Vaughan2, Claire L. Dobson2, and Jennifer L. Gallop1
Filopodia are finger-like actin-rich protrusions that extend from the cell surface and are important for cell–cell communication
and pathogen internalization. The small size and transient nature of filopodia combined with shared usage of actin regulators
within cells confounds attempts to identify filopodial proteins. Here, we used phage display phenotypic screening to isolate
antibodies that alter the actin morphology of filopodia-like structures (FLS) in vitro. We found that all of the antibodies that
cause shorter FLS interact with SNX9, an actin regulator that binds phosphoinositides during endocytosis and at invadopodia. In
cells, we discover SNX9 at specialized filopodia in Xenopus development and that SNX9 is an endogenous component of
filopodia that are hijacked by Chlamydia entry. We show the use of antibody technology to identify proteins used in filopodia-
like structures, and a role for SNX9 in filopodia.
Introduction
Assemblies of actin filaments (F-actin) are major dynamic su-
perstructures required for cell motility, intercell communica-
tion, and force generation. Filopodia contain parallel, tightly
bundled arrays of F-actin and protrude from the cell to traverse
substantial distances to detect substrate stiffness, the extracel-
lular matrix, and initiate cellular responses to growth factors.
Filopodia are hijacked by bacterial and viral pathogens during
cell entry and can also facilitate cell-to-cell transmission (Chang
et al., 2016).
Despite the fundamental importance of filopodia, as yet there
is no unifying model to explain how the actin cytoskeleton and
membrane machinery initiate, elongate, and sustain the dy-
namic behavior of filopodia.While filopodia appear to arise from
Arp2/3-dependent actin polymerization (Yang and Svitkina,
2011), there may also be other mechanisms of filopodia initia-
tion, such as via formins (Faix et al., 2009). Ena/VASP proteins
are important in filopodia formation in cortical neurons and
retinal ganglion cells, where their roles in elongating F-actin are
thought to be direct (Dent et al., 2007; Dwivedy et al., 2007).
However, in osteosarcoma cells, although reduced levels of Ena/
VASP proteins inhibit filopodia, they localize to focal adhesions
in the cell body rather than at filopodia tips, which suggests an
indirect role (Young et al., 2018).
Cell-free approaches allow the functional reconstitution of
specific actin assemblies and the biochemical analysis of their
components in response to lipid signals. Dynamic filopodia-like
structures (FLS) can be reconstituted using high-speed super-
natant Xenopus egg extracts and supported lipid bilayers aug-
mented with phosphatidylinositol (4,5) bisphosphate (Lee et al.,
2010). Our previous work has demonstrated that the initial stage
of FLS growth is sensitive to inhibition of Arp2/3 complex actin
nucleation whereas steady-state growth dynamics involve an
interchanging complement of F-actin elongation and bundling
proteins including the formin Drf3 (mDia2), Ena, VASP, and
fascin (Dobramysl et al., 2019 Preprint; Lee et al., 2010).
Here we have employed phage display phenotypic screening
for the de novo identification of proteins involved in making
FLS. In this approach, human single chain variable region
fragments (scFv) are displayed on the surface of bacteriophage
with the corresponding gene contained within their DNA. Phage
of interest can be selected in a binding assay, the sequence of the
variable region determined, and a specific antibody expressed
and purified. The antibodies are then used in a functional assay
to select those that generate phenotypes of interest, with the
antigen identified by protein array or immunoprecipitation
followed by mass spectrometry. While antibodies have much
recognized success in perturbing function extracellularly as
therapeutics and research tools, the use of cell-free systems
enables access to intracellular antigens.
We have identified antibodies against FLS that induce a va-
riety of morphological changes in the actin bundles. By selecting
the antibodies that generated shorter FLS, we identified the
antigen recognized by three independent antibodies as sorting
nexin 9 (SNX9) and subsequently demonstrated its role by im-
munodepletion and rescue experiments. Using human cell cul-
ture and Xenopus embryo explants, we have directly localized
SNX9 to filopodia. Thus, we show that phage display phenotypic
screening represents a powerful approach for identifying novel
proteins in cell-free systems, and the involvement of SNX9 in
filopodia.
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Results and discussion
Antibody-mediated modifications of FLS by phage display
phenotypic screening
To isolate antibodies targeting novel components of FLS, a phage
display library was incubated with a cocktail of purified actin
regulatory proteins that are known to localize to FLS to adsorb
and deselect phage against known FLS components (actin,
TOCA-1, Ena, VASP, N-WASP, fascin, and the Arp2/3 complex;
Lee et al., 2010). A further deselection step was performed
against the supported lipid bilayer and experimental setup,
followed by positive selection of phage on FLS (Fig. 1 A). We
performed screens against mature fully formed FLS, mature FLS
subjected to an additional washing step to relax the bundled FLS
architecture, and at an early time point where FLS were fixed
rapidly to ensure accessibility to the earliest arriving proteins.
Phages selected from each condition were eluted, cloned, and
sequenced. We excluded phages that bound under all three
conditions as they were more likely to bind residual proteins
from the extracts. Phage ELISA screening of each selection
output was performed against their respective condition and the
bilayer alone, and a panel of highly specific, strongly binding
clones was selected from each condition (Fig. 1 B). A single phage
that bound to the cocktail of known proteins was also selected
(scFv8). We purified 22 scFvs, which were individually pre-
incubated with the assay mix and resulting FLS visualized by
spinning disk confocal microscopy. We performed the screen
with and without additional unlabeled actin as lengthening
phenotypes could be constrained by limitations in the actin,
whereas shortening phenotypes could be suppressed by greater
actin concentrations.
Remarkably, a range of altered FLS phenotypes was evident
upon coincubation of different scFvs (Fig. 1 C). We quantified
FLS parameters using our image analysis pipeline FLSAce and
used the resulting median number, lengths and areas both with
and without additional actin as the input for the t-distributed
stochastic neighbor embedding (tSNE) algorithm to visualize
similarities between the actions of scFvs (Fig. S1 and Fig. 1 D).
The tSNE plot indicates several clusters (Fig. 1 D): scFvs 1, 9, and
19 are high in numbers, slightly longer and less straight; FLS in
scFv2 and scFv11 are among the longest and thinnest (i.e., have a
small FLS base area); in contrast, scFvs 6, 7, 8, and 14 are long as
well, but thicker; scFv10 and scFv17 are moderately high in
numbers with long FLS; scFvs 3, 4, 5, 18, and 20 show slightly
higher numbers and a reduction in FLS length; scFvs 12, 13, and
15 are slightly longer and show slightly higher numbers; and
scFvs 16, 21, and 22 show varying degrees of similarity to the
control.
The antibodies could be either blocking a single protein with
a single activity, giving a distinct phenotype; blocking a single
protein, giving complex effects due to the multiple roles of the
target protein; or reacting with more than one sequence related
protein and/or against a protein complex giving either simple or
complex phenotypes. Since the shorter phenotype could corre-
spond to the inhibition or sequestration of factors involved in
FLS formation or elongation, we focused our effort on the fur-
ther characterization scFv3 and scFv4 that generated substan-
tially shorter FLS.
SNX9 as a key mediator of FLS formation
To identify the target antigens, we probed Xenopus egg extracts
by immunoblotting with scFvs 3 or 4, with both recognizing a
70-kD species (Fig. 2 A). To enable immunoprecipitation, the
two scFvs were converted to an IgG1 framework to generate
monoclonal antibodies with higher avidity (correspondingly,
IgFls3 and IgFls4). These antibodies also recognized a 70-kD
species in Xenopus egg extracts (Fig. 2 B). Following separation
by SDS-PAGE and size exclusion by excision of regions of the gel
spanning ∼50–80 kD, eluted proteins were identified by mass
spectrometry by comparing extracts, immunoprecipitation (IP)
with control IgG and IP with IgFls3 (Fig. S2, A and B). The
highest scoring target of the right molecular weight was SNX9
(Fig. S2 C), a phox homology bin-amphiphysin-rvs (PX-BAR)
protein involved in endocytosis and control of actin polymeri-
zation (Yarar et al., 2007). Indeed, purified SNAP-tagged SNX9
was recognized by both scFv3 and scFv4 by immunoblotting
(Fig. S2 D).
To validate the requirement for SNX9, we used a previously
raised rabbit polyclonal antibody (Gallop et al., 2013) to im-
munodeplete SNX9 from Xenopus egg extracts and blotted with
IgFls3 and IgFls4. This showed a complete loss of the previously
recognized species at ∼70 kD (Fig. 2 B). A comparable result was
obtained when identical samples were immunoblotted with the
anti-SNX9 antibody, definitively identifying the ∼70-kD species
as SNX9 (Fig. 2 B). FLS generated using the SNX9-depleted
Xenopus egg extracts were significantly shorter (Fig. 2 C), a
phenotype rescued by the addition of purified SNX9 (Fig. 2 C).
The immunoblock induced by preincubation of extracts with
scFvs 3 or 4 could also be overcome by the addition of purified
SNX9 (Fig. 2, D–F; statistics are in Table S1). We additionally
looked at scFvs 5 and 21, which gave similar shorter FLS phe-
notypes in the initial screen (Fig. 1, C and D; and Fig. S1). Both
also recognized a 70-kD species in extracts; however, only scFv5
recognized purified SNX9 (Fig. S2 E). Similarly, while scFv5-
dependent inhibition of FLS was effectively relieved following
the addition of purified SNX9, this was less effective for scFv21
(Fig. 2, D–F; and Table S1), suggesting that scFv21 recognizes a
related protein rather than SNX9 itself.
To establish directly whether SNX9 localizes to FLS, we
supplemented the reaction mix with purified labeled SNAP-
SNX9, seeing enrichment at the tips of FLS where the actin
bundle grows from, marked by actin barbed end polymerase
VASP (Fig. 2 G). Equivalent localization was observed when
fixed FLS were immunostained with an anti-SNX9 antibody
(Fig. S2 F). Thus, SNX9 localizes to the membrane-proximal tip,
and is therefore likely a membrane-binding regulatory compo-
nent rather than a structural element distributed throughout the
actin bundle. Together, these data identify SNX9 as an important
mediator of FLS formation.
SNX9 is known to activate actin polymerization by binding
N-WASP downstream of its interaction with membranes, and
thereby stimulate Arp2/3 complex activation (Daste et al., 2017;
Gallop et al., 2013; Yarar et al., 2007). In cancer cells, over-
expression of SNX9 is thought to cause filopodia formation by
promoting Cdc42 activation, but the protein domain responsible
is not known (Bendris and Schmid, 2017; Bendris et al., 2016a,b).
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Using liposomes of defined lipid composition and Xenopus egg
extracts, which produces smaller actin assemblies compared
with FLS, we have previously found that the membrane inter-
action of SNX9 occurs via a dual interaction with phosphati-
dylinositol 4,5-bisphosphate (PI(4,5)P2) via the BAR domain and
PI(3)P with the PX domain (Daste et al., 2017; Gallop et al., 2013).
Since phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) and
phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2) are implicated
in filopodia formation via phosphoinositide 3-kinase (Jacquemet
et al., 2019; Johnson and Haugh, 2016), we investigated the effect
Figure 1. Phage display phenotypic screen on FLS. (A) Schematic of the screen. (B) Phage ELISA yes/no screening on selection outputs (n = 1) leading to the
identification of 22 unique phage clones specific to their FLS condition with lack of binding to the bilayer and setup (hatched boxes). (C) Example images of FLS
phenotypes on preaddition of 5 µl of each scFv of ∼1 mg/ml concentration to the FLS assay mix. Images are maximum intensity projections of 1 µm confocal Z
stack reconstructions viewed from the side. Scale bars, 10 µm. (D) T-distributed stochastic neighbor embedding plot of the 22 scFvs and buffer control (“C”).
The distance between the points shows a 2D representation of the 6D neighborhood structure spanned by each condition’s median FLS count, the median
average FLS length, and the median average FLS base area, for both additional actin added and no actin added. Each scFv is color coded.
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of inhibiting phosphoinositide 3-kinase on FLS and asked which
phosphoinositides were involved in FLS formation.
Recruitment of SNX9 and FLS formation was markedly re-
duced in the presence of phosphatidylinositol 3-kinase (PI3K)
inhibitors LY294002 and wortmannin, while the recruitment of
Fes/CIP4 homology-BAR (F-BAR) domain actin regulatory protein
TOCA-1 was unchanged (Fig. 3, A and B). Using purified phos-
phatidylinositol 3-phosphate (PI(3)P)-responsive mCh2xFYVE as
a lipid reporter, we could show that PI(3)P is produced from
supported lipid bilayers containing PI(4,5)P2, where it colocalizes
with sites of FLS growth (Fig. 3 B; statistics are in Table S2). We
then appliedwortmannin-treated extracts to PI(4,5)P2-containing
Figure 2. Identification of SNX9 as the antigen to antibodies giving a shorter FLS phenotype. (A) ScFv3 and 4 both detect a specific band not detected in
either control sample (red arrow) by Western blotting (left = 25 µg, right = 100 µg). The band at∼60 kD in all four blots (yellow arrow) is nonspecific reactivity
of the secondary or tertiary antibodies with extracts. (B) Western blots of control and SNX9 or mock-depleted extracts with IgGFls3, IgGFls4, or rabbit-anti
SNX9. The∼70 kD band is lost on SNX9 depletion. (C) Sidemaximum intensity projections of 1 µm confocal z-stacks of either mock or SNX9-depleted extracts.
Immunodepletion with anti-SNX9 antibodies reduces FLS length and is rescued by 20 nM purified SNX9. (D–F) Immunoblock (IB) by specific scFvs and rescue
by 20 nM purified SNX9. (D) Sidemaximum intensity projections of 1 µm confocal z-stacks of FLS grown using extracts immunoblocked with control or specific
scFVs. Reductions in FLS length and number can be rescued by addition of purified SNX9. (E and F) Quantification shows the median, quartiles, and range, n =
9–12 imaging regions per condition from two independent experiments. Statistics are in Table S1. (G) TIRFM shows colocalization of SNX9 and VASP with actin
and Z-maximal projection of a 1-µm confocal stack of actin in FLS. Scale bars, 10 µm.
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supported bilayers supplemented with PI(3)P, PI(3,4)P2 or
PI(3,4,5)P3. PI(3)P and not PI(3,4)P2 or PI(3,4,5)P3 rescues FLS
formation, confirming it is the active lipid (Fig. 3, C and D). The
functional activity of PI(3)P in FLS may suggest that PI(3,4,5)P3
and PI(3,4)P2 in filopodia are dephosphorylated to produce PI(3)
P for actin nucleation in filopodia, similar to our observations in
endocytosis (Daste et al., 2017).
SNX9 localizes to the tip and shaft of cellular filopodia
While FLS allow biochemical analysis, they lack a boundary
membrane, so we asked whether SNX9 is a component of cel-
lular filopodia. Filopodia can be readily visualized in open-face
dorsal marginal zone explants from Xenopus embryos that un-
dergo convergent extension, where they are implicated in gen-
erating the forces of tissue movement (Belmonte et al., 2016;
Keller et al., 2000). We coexpressed mCherry-SNX9 and the
plasma membrane marker GFP-CAAX, observing SNX9 at the
tips of a subset of extending filopodia, which were frequently
observed clustered together in distinct subregions of the ex-
plants, suggesting they may have specialized functional prop-
erties (Fig. 4 A, Fig. S3 A, and Video 1).
We next investigated the localization of endogenous SNX9 in
human cells by indirect immunofluorescence of HeLa and reti-
nal pigment epithelial (RPE-1) cells, using two independent
commercial human anti-SNX9 antisera. The specificity of the
antibodies for SNX9 was confirmed as the immunofluorescence
signal was markedly reduced following siRNA-mediated SNX9
knockdown (Fig. 4 B and Fig. S3 B; Ford et al., 2018). There were
similar numbers of filopodia in control and SNX9 knockdown
cells (Fig. S3 C), which may be expected given that filopodia are
still observed on Arp2/3 complex knockout (Suraneni et al.,
2012; Wu et al., 2012). Strikingly, however, SNX9 was present
in ∼90% of filopodia and was present within the shaft as well as
at the tip (Fig. 4, B–D).
Intriguingly, SNX9 is implicated in the filopodial capture of
extracellular Chlamydia trachomatis by human cells (Ford et al.,
2018). A correlative decrease in both filopodial number and
bacterial internalization was observed when SNX9−/− knockout
HAP1 cells were infected, a deficit that was partially overcome by
sedimenting bacteria onto the cells (Ford et al., 2018). Conse-
quently, we examined the relationship between infectious C.
trachomatis elementary bodies (EBs), endogenous SNX9, and
filopodia during the initial minutes of the host–pathogen inter-
action. Clusters or single infectious EBs were observed in asso-
ciation with the tips and shafts of SNX9-positive filopodia, which
often appeared to capture EBs at a distance from the cell surface
(Fig. 4 D, panels a–d; and Fig. S3, D–F). Rather than C. trachomatis
inducing SNX9 filopodia, for example by using a SNX9-binding
translocated bacterial effector, our findings suggest SNX9 is
endogenously present in filopodia that are hijacked by C. tra-
chomatis to drive entry. While the C. trachomatis entry mecha-
nism shows some similarities with the determinants of FLS
formation, it is not sensitive to either wortmannin or LY294002
(Ford et al., 2018). Thus, as is typical of pathogen subversion of
target cells, it is likely that bacterial virulence factors replace or
reprogram cellular factors to ensure deviation of bacterial-
containing vacuoles from the canonical endocytic pathway.
Because of its known roles in responding to phosphoinositide
lipids, endocytosis, and actin regulation, SNX9 is a candidate
molecule integrating signaling, membrane traffic, and filopodia.
Molecular differences have been observed between different
filopodia, and SNX9 localization to a subset of filopodia in vivo
supports that there may be molecular specializations appropri-
ate to different cellular contexts. In early Xenopus development,
many vesicles traffic within filopodia (Danilchik et al., 2013),
suggesting that the shaft localization we obtained in fixed cells
could correspond to vesicles trafficking within filopodia. These
appear responsible for C. trachomatis entry, and from the in vitro
work, also appear important in building the filopodium. In
agreement with this, inhibiting endocytosis freezes filopodia
dynamics (Bu et al., 2009; Gallop, 2019; Nozumi et al., 2017). Our
work sheds light on the cellular mechanisms by which SNX9 is
involved in development, cancer metastasis, and pathogen entry
and holds promise for further molecular dissection of FLS
in vitro and filopodia in vivo.
Materials and methods
Cell lines
RPE-1 cells (ATCC CRL-4000, RRID:CVCL 4388) are an immor-
talized line derived from human female retinal pigmental epi-
thelial tissue. They were maintained in DMEM/F12 media
(Sigma-Aldrich, D6421) supplemented with 10% fetal bovine
serum, 0.25% sodium bicarbonate (both Sigma-Aldrich), 100 µg/
ml penicillin/100 U/ml streptomycin, and 2mML-glutamine (all
Gibco). HeLa (ATCC CCL-2, RRID:CVCL 0030) cells (derived
from human cervical adenocarcinoma) were maintained in
DMEM (high glucose + glutamax, Gibco) containing 10% FBS and
100 µg/ml penicillin/100 U/ml streptomycin. Both lines were
grown at 37°C in a humidified incubator containing 5% CO2, and
were subcultured twice weekly.
Xenopus laevis
X. laevis (RRID:XEP_Xla100) were used as both a source for the
egg extracts used in FLS assays and as a model organism in
Xenopus embryo explant experiments.
Male and female X. laevis were housed in the aquatic facility
at the Gurdon Institute. Xenopus were housed in a Marine Biotech
recirculating system, with 12 h light/dark cycles, and fed a com-
mercial trout pellet diet. Female X. laevis were used for egg col-
lection only. To induce superovulation, adult female X. laeviswere
injected with 150 IU pregnant mare’s serum gonadotrophin–
Intervet (MSD Animal Health) 4–7 d pre-experiment and 400 iU
human chorionic gonadotrophin 12–18 h pre-experiment. Primed
Xenopus were kept in Marc’s modified Ringers’ (MMR) solution
(100 mM NaCl, 5 mM Na-Hepes, pH 7.8, 2 mM KCl, 2 mM CaCl2,
1 mM MgCl2, and 0.1 mM EDTA). Male X. laevis were used for
testes extraction. Male Xenopus were euthanized by subcutaneous
injection of MS222. In vitro fertilization was performed by
swirling mashed testis through collected eggs. The resultant em-
bryos were injected with RNA at the two-cell stage, then main-
tained at 14°C, with explants taken at Nieuwkoop and Faber Stage
10. This research has been regulated under the Animals (Scientific
Procedures) Act 1986 Amendment Regulations 2012 after ethical
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Figure 3. Class I PI3K is involved in FLS formation with PI(3)P being a key downstream lipid. (A) TIRF and confocal imaging of representative FLS regions
containing labeled SNX9 (TIRF), TOCA-1 (TIRF), or actin (maximally projected confocal side or Z views) treated with DMSO or 100 µM LY294002. Both SNX9
and actin but not TOCA-1 are reduced by the inhibitor. (B) TIRF and confocal imaging of representative FLS regions containing labeled SNX9, the PI(3)P probe
mCh-2xFYVE (TIRF), or actin (maximally projected confocal side or Z views) grown on membranes containing 10% PI(4,5)P2 or 10% PI(4,5)P2 plus 5% PI(3)P, 5%
PI(3,4)P2 or 5% PI(3,4,5)P3 and treated with either DMSO or 2 µMwortmannin. SNX9, mCh-2xFYVE, and actin are reduced on wortmannin treatment. Inclusion
of 5% PI(3)P shows mCh-FYVE labeling and SNX9 recruitment in the presence of wortmannin and 5% PI(3,4)P2 or 5% PI(3,4,5)P3 do not. (C and D) Quanti-
fication of data in B. Each datapoint represents an individual imaging region (n = 24 regions for each treatment from two independent experiments). Lines
indicate mean ± SEM. Statistical significance was assessed by ordinary one-way ANOVA with Holm–Sidak’s multiple comparisons test (Table S2). Scale bars,
10 µm. n.s., not significant.
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Figure 4. SNX9 localizes to filopodia in Xenopus gastrula explants and human cultured cells. (A) Background-subtracted single frames from a TIRFM
time-lapse sequence taken at 2-s intervals of Xenopus chordamesoderm cells expressing mCh-SNX9 and GFP-CAAX membrane marker shows SNX9 tracking a
growing filopodium tip. Scale bar, 2 µm. (B) Confocal images of RPE-1 cells treated with either scramble or SNX9 siRNA and immunolabeled with rabbit anti-
human SNX9 and phalloidin; endogenous SNX9 is in RPE-1 cell filopodia and is abolished on knockdown. Scale bar, 5 µm. (C)Quantification of SNX9 in filopodia
in uninfected RPE-1 and in cells infected with C. trachomatis. Each data point represents an individual imaging region; lines indicate mean ± SD. For infected
cells, n = 248 filopodia from 62 cells across n = 11 images, for uninfected, n = 416 filopodia from 139 cells across n = 20 images. Unpaired t test, P = 0.9958 (n.s.).
(D) a–d: Example images of phase contrast and fluorescence confocal images of RPE-1 cells infected with C. trachomatis and immunolabeled for SNX9 and
phalloidin show C. trachomatis sticking to filopodia containing SNX9. Scale bars, 2 µm.
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review by the University of Cambridge Animal Welfare and Eth-
ical Review Body and covered by Home Office Project License
P1B9A7D57 (license holder: J.L. Gallop) and Home Office Personal
licenses held by J.L. Gallop, T. Jones-Green, and J. Mason.
Preparation of Xenopus egg extracts
High-speed supernatant Xenopus egg extracts were prepared
according to our usual methods (Walrant et al., 2015). Briefly,
eggs from up to 10 Xenopuswere dejellied inMMR containing 2%
wt/vol cysteine (adjusted to pH 8.0), then gently washed in
Xenopus extracts buffer (XB: 100 mM KCl, 100 nM CaCl2, 1 mM
MgCl2, 50 mM sucrose, and 10 mM K-Hepes, pH 7.4), followed
by extract buffer for cytostatic factor extracts (CSF-XB: 100 mM
KCl, 10 mM K-Hepes, pH 7.4, 5 mM EGTA, 2 mM MgCl2, and
50 mM sucrose). Following addition of protease inhibitor
cocktail (Sigma-Aldrich P8340) and Energy Mix (final 1× con-
centration 2 mMATP, 15 mM creatine phosphate, 2 mMMgCl2),
eggs were transferred to thin-wall centrifuge tubes and crushed
by centrifugation at 17,800 g (in a SW-40 Ti rotor [Beckman-
Coulter] for 10 min at 4°C). The crude cytoplasmic extract layer
was extracted using a needle and diluted 10-fold in XB, then
spun at 260,000 g in a Ti-70 rotor (Beckman-Coulter) for 1 h at
4°C to prepare high-speed supernatant. This supernatant was
filtered through a 0.22-µm syringe filter unit, then spin-
concentrated in a 10-kD molecular weight cut off (MWCO)
spin concentrator (Amicon) to a final concentration of 25mg/ml.
Extracts were then supplemented with 200 mM sucrose and
snap frozen in liquid nitrogen for storage at –80°C.
Preparation of supported lipid bilayers
Supported lipid bilayers were prepared according to our usual
methods (Walrant et al., 2015). Briefly, 2 mM total lipid lip-
osomes were prepared containing, by mol fraction, 10% PI(4,5)
P2, 30% PS, and 60% phosphatidylcholine (Avanti Polar Lipids,
840046X, 840032C, and 840053C). For experiments that also
included 5% PI(3)P, 5% PI(3,4)P2, or 5% PI(3,4,5)P3 (Avanti Polar
Lipids, 850150P, 850153P, and 850156P), the amount of phos-
phatidylcholine was reduced to 55%. To prepare liposomes, lipid
stocks were mixed together and dried under a constant stream
of nitrogen, then under vacuum for 1 h, after which the lipid film
was resuspended to the final 2 mM total lipid concentration in
XB, and sonicated in a bath sonicator for 15min. Liposomes were
added to wells formed by silicone gaskets (Grace Bio-Labs,
supplied by Stratech Scientific, 103280) and placed on glass
coverslips or glass-bottomed ProplateMicrotiter Plates (Stratech
Scientific, 204969) according to the experiment, and after ad-
sorption and fusion to the glass surface, supported bilayers were
washed several times with XB.
Phage display screening and generation of antibodies
Isolation of anti-FLS antibodies
Supported lipid bilayers were prepared on Proplate Microtiter
Plates. FLS assays were performed according to our usual
methods (Walrant et al., 2015). Briefly, assay mix comprising
6 mg/ml Xenopus egg extracts, 2 mM DTT, 5 µM actin, energy
regenerating system (Energy Mix; final concentration 2 mM
ATP, 15 mM creatine phosphate, and 2 mM MgCl2) in XB was
added to the supported bilayers and incubated for 15 min at
room temperature (Walrant et al., 2015). For the mature FLS
condition, 2 µl phalloidin (Thermo Fisher Scientific, P3457) from
a 10 mg/ml methanol stock was added and incubated for a fur-
ther 5 min followed by three washes with XB and fixation with
4% formaldehyde for 75min. For the washed FLS condition, after
15 min of FLS growth, three washes with XB were performed
then the FLS stabilized by addition of 2 µl phalloidin. After a
5 min incubation, assays were washed three times with XB and
fixed with 4% formaldehyde in XB for 75 min. For the early FLS
condition, the assay mix was removed after 3 min and washed
three times with XB. 2 µl phalloidin was added, and the mix was
incubated for 5 min, then fixed with 4% formaldehyde in XB for
75 min. Fixed FLS were kept at 4°C for up to 3 d. Phenotypic
selections were performed using the CAT2.0 human scFv phage
display library (Lloyd et al., 2009; Vaughan et al., 1996). Three
rounds of selection were performed against each of three dif-
ferent filopodia structures: the mature, the washed, and the
early time point. Wells were washed with PBS and then blocked
for 1 h with PBS-Marvel milk powder (3% wt/vol). 109–1012
phages were blocked for 1 h at room temperature in PBS-Marvel
milk powder (3% wt/vol) and then transferred to wells coated
with lipid bilayers and purified FLS proteins to deplete non-
specific and known binders. The blocked phages were subse-
quently incubated with the appropriate FLS condition for 1 h at
room temperature and any unbound phage removed by a series
of wash cycles using PBS-Tween (0.1% vol/vol) and PBS. Bound
phage particles were eluted by addition of 5 µg/ml trypsin, in-
fected into Escherichia coli TG1 bacteria and rescued for the next
round of selection (Vaughan et al., 1996).
Phage ELISA
Following three rounds of phage display selection, individual
scFv were prepared as phage supernatants, and the round 2 and
3 outputs screened by phage ELISA for binding to the corre-
sponding filopodia structures used for selections (Osbourn et al.,
1996; Vaughan et al., 1996). Nunc Maxisorp (Immobiliser) plates
(Thermo Fisher Scientific, 44–2404-21) coated with lipid bi-
layers and a mix of purified TOCA-1, fascin, Arp2/3 complex,
N-WASP, Ena, and VASP as described in (Dobramysl et al., 2019
Preprint) were used for negative selection. Specific clones, de-
fined as those which gave more than threefold signal over
background, were sequenced, expressed in TG1 E. coli, and pu-
rified via the C-terminal His tag by immobilized nickel chelate
chromatography (Bannister et al., 2006; Lloyd et al., 2009).
Reformatting of scFv to IgG1 TM
Antibodies were converted from scFv to whole immunoglobulin
G1 triple mutant (IgG1-TM, IgG1 Fc sequence incorporating
mutations L234F, L235E, and P331S) antibody format essentially
as described by Persic et al. (1997) with the following mod-
ifications. An OriP fragment was included in the expression
vectors to facilitate use with CHO-transient cells and to allow
episomal replication. The variable heavy domainwas cloned into
a vector containing the human heavy chain constant domains
and regulatory elements to express whole IgG1-TM heavy chain
in mammalian cells. Similarly, the variable light domain was
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cloned into a vector for the expression of the human light chain
(lambda) constant domains and regulatory elements to express
whole IgG light chain in mammalian cells. The plasmids were
cotransfected into CHO-transient mammalian cells (Daramola
et al., 2014) and IgG proteins purified from cell culture me-
dium using Protein A chromatography. The purified IgG were
analyzed for aggregation and degradation purity using size ex-
clusion chromatography–-HPLC and by SDS-PAGE.
Cloning
X. laevis SNX 9 (accession no. BC077183) was PCR-amplified from
IMAGE clone 3402622 (Source Bioscience) and cloned into either
pCS2 N-terminal GFP or pCS2 N-terminal mCherry (primers 59-
GCATGGCCGGCCACCATGAACAGCTTTGCGG-39 and 59-GGCGCG
CCTCACATCACTGGG-39). GFP-Utrophin-CH was PCR amplified
from a pCS2 construct (gift from S. Woolner (University of
Manchester, Manchester, UK; Burkel et al., 2007) and cloned
into pGEX FA acceptor vector (primers 59-GCATGGCCGGCCACC
ATGGTGAGCAAGGG-39 and 59-GGCGCGCCCTTGAGCTCGAGT
TAGTCTATG-39). pCS2-his-SNAP-X. laevis SNX9 was previously
described (Daste et al., 2017). pET-his-SNAP-Xenopus tropicalis-
Toca1 and pET-KCK-VASP were previously described (Dobramysl
et al., 2019 Preprint). pCS2-GAP-RFP was a gift from C. Holt
(University of Cambridge, Cambridge, UK). pCS2-GFP-CAAX was
a gift from M. Kirschner (Harvard Medical School, Boston, MA).
Protein purification
All chemicals and reagents were from Sigma-Aldrich unless
otherwise stated. 6xHis-SNAP-TOCA-1 and 6xHis-GFP-Utrophin
in pET or pGEX plasmids, respectively, were transformed into
BL21 pLysS E. coli, with protein expression induced overnight at
19°C. The 6xHis-SNAP-SNX9 pCS2 construct was transfected
into 293F cells by 293fectin reagent (Thermo Fisher Scientific)
according to the manufacturer’s instructions, and cells were
harvested 48 h later. All purification steps were performed at
4°C. Bacteria or 293F cells were harvested by centrifugation and
resuspended in a buffer containing 150 mM NaCl, 20 mM Na-
Hepes, pH 7.4, 2 mM 2-mercaptoethanol, and EDTA-free cOm-
plete protease inhibitor tablets, after which they were lysed by
probe sonication. Lysates were spun at 40,000 rpm for 45min in
a 70Ti rotor (Beckman-Coulter), with supernatants then applied
to nickel nicotinamideagarose beads (Qiagen, L30210) for af-
finity purification. Proteins were eluted by applying stepwise
increasing concentrations of imidazole (50–300 mM) in a buffer
containing 150 mM NaCl, 20 mM Na-Hepes, pH 7.4, and 2 mM
2-mercaptoethanol. 6xHis-KCK-VASP in the pET15b plasmid
was transformed into Rosetta DE3 pLysS cells and expression
induced as for the pET constructs above. The protein was puri-
fied as above, with the following differences: all buffers con-
tained 300mMNaCl rather than 150mM, and the beads used for
affinity purification were cobalt agarose beads (Talon Superflow,
GE Healthcare, GE28-9574-99). For all proteins, fractions con-
taining eluted protein were further purified using S200 gel fil-
tration on an AKTA FPLC (GE healthcare) in a buffer containing
150 mM NaCl (300 mM for KCK-VASP), 20 mM Na-Hepes, pH
7.4, 2 mM EDTA, and 5 mM DTT. Purification was verified by
SDS-PAGE electrophoresis and Coomassie staining, with positive
fractions pooled and concentrated in a 10 kD MWCO spin concen-
trator (Millipore). Concentration was verified by A280 measure-
ments on a Nanodrop, and proteins had 10% glycerol added before
they were snap-frozen in liquid nitrogen and stored at –80°C.
Chemical labeling of proteins with fluorescent dyes
SNAP-tagged TOCA-1 and SNX9 were labeled using SNAP-
Surface Alexa Fluor 488 or Alexa Fluor 647 (New England Bio-
labs, S9129S, S9136S). 5–10 µM final concentration of protein
was mixed with 10 µM SNAP-dye in a buffer containing 150 mM
NaCl, 20 mM Na-Hepes, pH 7.4, 1 mM DTT, and 1% (vol/vol)
TWEEN 20 and incubated under gentle rotation at 4°C over-
night. The labeled protein was dialysed into a buffer containing
150 mM NaCl, 20 mM Na-Hepes, pH 7.4, and 10% glycerol in a
0.1-ml 20-kD MWCO Side-A-Lyzer MINI Dialysis device
(Thermo Fisher Scientific) to remove excess dye; dialysis oc-
curred in two rounds over a 24-h period. KCK-VASP was labeled
at 4°C overnight by adding a 10–20 foldmolar excess of the Alexa
Fluor 568 maleimide dye (Thermo Fisher Scientific, A-20341) to
a 50 µM final concentration of the protein in the presence of a
10-fold molar excess of TCEP under gentle rotation. Excess dye
was removed by buffer exchange into 300mMNaCl, 20mMNa-
Hepes, pH 7.4, and 10% glycerol using an Ultra-15 centrifugal
filter unit spin concentrator (Amicon) with an Ultracel-10
membrane (Millipore).
Immunodepletion
SNX9 was immunodepleted from Xenopus egg extracts using a
rabbit anti-Xenopus SNX9 antibody, as previously described
(Gallop et al., 2013). Three rounds of depletion were performed
using Protein A beads (Thermo Fisher Scientific, 10002D).
Briefly, 300 µl antibody serum (SNX9 and prebleed serum as
mock sample) was bound to 75 µl Dynabead protein A beads for
1 h at room temperature with continuous rotation. Beads were
washed with 1 × PBS + 0.1% Tween (PBST), PBST plus 500 mM
NaCl, and XB buffer and then divided into three 25-µl aliquots.
100 µl Xenopus egg extracts were incubated subsequently with
each aliquot of beads for 30 min at 4°C with rotation for each
incubation. The resulting depleted and mock-depleted egg ex-
tracts were analyzed byWestern blotting with IgFls3, IgFls4, and
rabbit anti-Xenopus SNX9 antibody used as primary antibodies,
and mouse anti-human IgG1 Fc secondary antibody, HRP sec-
ondary antibody for the IgGs, and IRDye 800CW goat anti-rabbit
IgG secondary antibody for the SNX9 antibody.
FLS assays
FLS assays were performed according to our usual methods on
glass coverslips in wells defined by silicone gaskets (Walrant
et al., 2015). The basic reaction mix was composed of a 1:6 di-
lution of 25 mg/ml Xenopus egg extracts, 2 mMDTT, EnergyMix,
1 µM unlabeled rabbit skeletal muscle actin (Cytoskeleton,
AKL99), and 210 nM fluorescently labeled actin (Alexa Fluor
488, 568, or 647, Thermo Fisher Scientific, A12373, A12374,
A34051), made up in XB, and supplemented with other labeled
proteins, antibodies, or inhibitors as necessary for the specific
experiment. 50 µl of reaction mix was gently added to the
supported lipid bilayer and incubated at room temperature for
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25 min before imaging. For the screening of the scFvs, 5 µl of the
individual scFv was added to the basic reaction mix. For ex-
periments involving the rescue of FLS prepared using mock/
SNX9-immunodepleted or scFV-treated extracts, 20 nM of SNX9
was added, and rather than using fluorescently labeled actin,
33 µM of GFP-utrophin was used to label FLS (Burkel et al.,
2007). For experiments in which the localization of fluo-
rescently labeled recombinant purified proteins was analyzed,
they were included in the reaction mix at the following con-
centrations: 20 nM VASP, 30 nM SNX9, 10 nM TOCA-1, and
1 µg/ml mCh-2xFYVE. For experiments involving the addition of
inhibitors to FLS, inhibitors (or appropriate dilutions of the
vehicle, DMSO) were prepared as 10× stocks in XB, with 5 µl
then added to complete the 50 µl reaction mix. The mixes were
then incubated for 10 min before being added to the supported
lipid bilayer to start the experiment. Inhibitors were used at the
following final concentrations: 2 µM wortmannin (Sigma-Al-
drich, W-1628), and 100 µM LY294002 (Selleck Chemicals,
S1105).
Immunolabeling of FLS
FLS were prepared using an assay mix comprised of 6 mg/ml
Xenopus egg extracts, 2 mM DTT, Energy Mix, and 210 nM flu-
orescently Alexa Fluor 568–labeled actin made up in XB, which
was added to the supported bilayers and incubated for 15 min at
room temperature, after which 0.5 µl phalloidin from a 10 mg/
ml methanol stock was added. Following a further 5 min incu-
bation, FLS were washed twice in XB, then fixed in 4% formal-
dehyde made up in cytoskeletal buffer 10 mM MES, pH 6.1,
138 mMKCl, 3 mMMgCl2 and 2 mM EGTA) for 1 h. Following 3×
PBS washes, FLS were blocked in 2% BSA-PBS for 1 h. Primary
antibody mixes were made up in PBS; FLS were stained with the
rabbit anti-Xenopus SNX9 antibody (1:100 dilution) for 1 h. Fol-
lowing 3× PBS washes, the secondary antibody mix (goat anti-
rabbit Alexa Fluor 488 [Thermo Fisher Scientific, A-11008],
made up in PBS) was added for 1 h. Fixed and labeled FLS were
washed three further times in PBS, then immediately imaged.
Western blotting using FLS ScFvs and IgG1-TMs
Samples of either Xenopus egg extracts or purified recombinant
SNX9 were run on 4–20% mini-PROTEAN precast protein gels
(Biorad) and transferred to nitrocellulose membrane using an
iblot 2 dry blotting system. Western blots using ScFvs were
blocked in 10% milk/PBST, incubated with 4.5 µg/ml ScFv in 1%
milk/PBST for 1 h at room temperature, washed with PBST, and
then incubated overnight with a 1/1,000 dilution in 1% milk/
PBST of either rabbit anti-his antibody (Abcam, ab9108) or
mouse anti-myc antibody (Roche, 11667149001). After washing
the membranes, tertiary incubations were performed with a
1/10,000 dilution in 1% milk/PBST of either anti-rabbit or anti-
mouse 800 CW antibody (LI-COR Biosciences, 926–32210 and
926–32211), washed, and imaged using an Odyssey Sa Reader (LI-
COR Biosciences). Western blots using Fls IgGs were blocked in
5% milk/1 × TBS + 0.1% Tween. Antibody incubations were
performed in antibody diluted in 5%milk/1 × TBS + 0.1% Tween.
Fls IgGs were diluted to 2.5 µg/ml and the secondarymouse anti-
Human IgG1-HRP antibody (Thermo Fisher Scientific, A-10648)
used at 1/500 dilution. HRP was detected using the ECL Prime
Western blotting system (GE Healthcare, GERPN2232).
Immunoprecipitation
For immunoprecipitation of IgG-FLS antigens, we employed a
gravity flow column format as follows, with all steps conducted
at 4°C. 2 ml of Affigel 10 matrix (BioRad, 1536099) slurry (1 ml
column bed volume) was added to a poly prep chromatography
column (BioRad) and washed with three bed volumes of ice-cold
water under gravity flow. IgG antibody was incubated with the
immunoaffinity resin at a concentration of 1 mg/ml in 20 mM
Hepes, pH 7.4; 1 × PBS and columns were rotated overnight at
4°C. Affigel activated affinity resin binds to free primary amines
and therefore it was necessary to block unreacted residues in
order to avoid nonspecific protein binding, by the addition of
100 µl of 1 M ethanolamine (pH 8.0) spiked into the resin/an-
tibodymix. The columnwas left to rotate for 1 h at 4°C. Unbound
supernatant was eluted from the resin under gravity flow, and
the column was washed with eight column bed volumes of
20 mM Hepes, pH 7.4. The efficiency of antibody binding to the
matrix was evaluated by SDS-PAGE before proceeding to the
next step. 1 ml of Xenopus egg extracts (∼12 mg/ml concentra-
tion) were mixed with 20 µl 10% Tween, 200 µl 10× XB, and
780 µl water and loaded onto the IgG-bound column. The col-
umns were rotated overnight at 4°C in the presence of the
antigen-containing extracts. Unbound supernatant was re-
moved from the column under gravity flow, and the columnwas
washed with 10 ml 0.5 M NaCl, followed by three 10-ml washes
with binding buffer (20 mM Hepes, pH 7.4, 1 × PBS). All flow-
through and wash samples were retained for further analysis.
Elution of the antibody-bound antigen was enabled by 10 se-
quential additions of 250 µl elution buffer (200 mM glycine, pH
2.5, 150 mM NaCl). Each of the 10 eluates were collected into
separate tubes and immediately neutralized by the addition of
50 µl 1 M Tris, pH 8.0. In total, three samples were processed in
parallel: (1) immunoprecipitation with the FLS-IgG of interest,
(2) immunoprecipitation with a control IgG antibodywas used to
assess nonspecific binding to IgG, and (3) a column with resin
was prepared (as above) and incubated with extracts without the
addition of IgG, to account for nonspecific binding of proteins to
the resin matrix.
Proteolytic digestion and liquid chromatography tandemmass
spectrometry (LC-MS/MS)
Immunoprecipitated eluates from (1) IgFls3 IgG, (2) control IgG,
and (3) Xenopus egg extracts + resin were concentrated by vac-
uum centrifugation (Labconco), run on 4–15%Mini-Protean TGX
gels (Bio-Rad), and stained with Instant Blue Coomassie stain
(Sigma-Aldrich). The fourth elution of the 10 sequential eluates
was processed for LC-MS/MS, as this was the sample containing
the antigen of interest identified by immunoblotting. Bands
were excised from the Coomassie gel corresponding to the
50–80-kD region and processed for mass spectrometry as fol-
lows. Gel pieces were cut into 1–2-mm cubes, destained by
several washes in 50% (vol/vol) acetonitrile, 100 mM ammoni-
um bicarbonate solution, and then dehydrated with 100% (vol/
vol) acetonitrile. Disulfide reduction was achieved by incubation
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with 10 mM DTT at 37°C for 1 h, followed by alkylation of cys-
teine residues with 5 mM iodoacetamide at room temperature
protected from light for 1 h, where both solutions were made in
100 mM ammonium bicarbonate. Gel pieces were washed sev-
eral times in 50% (vol/vol) acetonitrile, 100 mM ammonium
bicarbonate solution at 37°C, before being dehydrated in 100%
(vol/vol) acetonitrile. Proteolytic digestion was achieved by the
addition of 50 µl sequencing-grade modified trypsin (Promega)
at a concentration of 10 ng/µl in 50mMammonium bicarbonate.
A further aliquot of trypsin solution was added after 1 h to en-
sure gel pieces remained hydrated during overnight incubation
at 37°C. The supernatant containing the eluted peptides was
retained and analyzed by LC-MS/MS analysis with a Waters
nanoAcquity UPLC (Thermo Fisher Scientific) system coupled to
an Orbitrap Velos mass spectrometer (Thermo Fisher Scientific).
Peptides were first loaded onto a precolumn (Waters UPLC Trap
Symmetry C18, 180-µm internal diameter. × 20 mm, 5 µm
particle size) and eluted onto a C18 reverse-phase column at a
flow rate of 300 nl/min (nanoAcquity UPLC BEH C18; 75-µm
internal diameter × 250 mm, 1.7 µm particle size, Waters) us-
ing a linear gradient of 3–40% buffer B over 40min (60min total
run time including high organic wash and reequilibrium steps).
Buffer A was 0.1% formic acid in HPLC-grade water (vol/vol);
buffer B was 0.1% formic acid in acetonitrile (vol/vol). The mass
spectrometer was operated using data-dependent tandem mass
spectrometry acquisition in positive ion mode. Full scans
(380–1,500 m/z) were performed in the Orbitrap with nominal
resolution of 30,000. The top 20most intense monoisotopic ions
from each full scan were selected for collision-induced dissoci-
ation in the linear ion trap with a 2.0m/z precursor ion selection
window and normalized collision energy of 30%. Singly charged
ions were excluded from tandem mass spectrometry, and a dy-
namic exclusion window of ±8 ppm for 60 s was applied.
Xenopus embryo explants
Capped RNA synthesis
CAAX-GFP and mCherry-SNX9 capped RNA was synthesized
using the mMESSAGE mMACHINE SP6 transcription kit (In-
vitrogen, AM1340) from NotI linearized pCS2 CAAX-GFP and
pCS2 his mCherry SNX9 plasmids. Linear DNA was cleaned up
before transcription using the QIAquick PCR purification kit
(Qiagen). 1 µg purified linear DNA was added to a standard
mMESSAGE mMACHINE transcription reaction with the addi-
tion of 2 U/µl of Murine RNase inhibitor (New England Biolabs)
and incubated for 2 h at 37°C. Unincorporated nucleotides were
removed using the RNeasy mini kit (Qiagen).
RNA injection and Keller explants
9.2 nl of a solution containing both capped RNAs at 30 ng/µl was
injected into each cell of dejellied two-cell Xenopus embryos
maintained in MMR containing 4% Ficoll. The injected embryos
were transferred to 0.1 × MMR solution after undergoing a
minimum of one cell division and cultured at 14°C. Briefly, to
visualize Xenopus chordamesoderm cells, explants of dorsal
mesendoderm and ectoderm were prepared from the injected
embryos at the early gastrula stage (Keller and Danilchik, 1988).
The vitelline membrane was removed and a section of dorsal
mesendoderm and ectoderm extending from the bottle cells
removed using an eyebrow knife and hair loop and cleaned of
loose mesoderm cells. Explants were placed under a glass bridge
in 53mMNaCl, 32mMNa-gluconate, 4.5 mMK-gluconate, 1 mM
CaCl2, 1 mM MgSO4, and 5 mM Na2CO3, pH 8.3, with Hepes for
3 h at room temperature, and then imaged.
Immunostaining of cells and Chlamydia infection
RPE-1 and HeLa cells were infected with wild-type C. trachomatis
LGV2 as described previously (Ford et al., 2018). Briefly, cells
were cultured on coverslips and infected with C. trachomatis at a
multiplicity of infection of 5–30. To synchronize Chlamydia en-
try, bacteria were spinoculated at 900 g for 10min. After 30min
at 37°C, samples were fixed and immunostained. For staining
with mouse anti-human SNX9 antibody ([2F1], Abcam,
ab118996), samples were fixed in 4% (wt/vol) paraformaldehyde
in PBS for 20 min at room temperature. After fixation, samples
were blocked in blocking solution (10% FCS in PBS + 0.2% [wt/
vol] saponin) for 1 h, and then incubated for 1 h with primary
antibody (1/100 in PBS + 3% FCS + 0.2% saponin), washed three
times in PBS, and finally incubated for 1 h with goat anti-mouse
IgG coupled to Alexa Fluor 568 (Thermo Fisher Scientific,
A-11004, 1/500 in PBS + 3% FCS + 0.2% saponin), phalloidin
coupled to Alexa Fluor 488 (Thermo Fisher Scientific, A12379,
1/100), and DAPI (Thermo Fisher Scientific, 62247, 1 µg/ml). For
staining with rabbit anti-SNX9 antibody ([EPR14399] Abcam,
ab181856), samples were fixed according to the “Golgi fixation
method” described by Hammond et al. (2009). Samples were
fixed for 15 min in 2% (wt/vol) formaldehyde in PBS. After
fixation, samples were permeabilized for 5 min in per-
meabilization solution (20 µM digitonin, in buffer A: 150 mM
NaCl, 20 mMHepes, and 2 mM EDTA). Samples were blocked in
blocking solution (10% goat serum in a buffer A) for 45 min,
before incubation for 1 h with primary antibody (diluted 1:100 in
buffer A + 1% goat serum), and then for 45 min with goat anti-
rabbit IgG coupled to Alexa Fluor 647 (Thermo Fisher Scientific,
A-21244, 1/1,000 in buffer A + 1% goat serum), phalloidin coupled
to Alexa Fluor 488, and DAPI. Samples were finally fixed after
staining for 5 min in 2% (wt/vol) formaldehyde solution.
siRNA treatment
siRNA was used to knock down SNX9 expression in RPE-1 cells.
Cells were seeded at an appropriate density on glass coverslips
or tissue culture plates. 5 µl anti-SNX9 siRNA (59-AACAGTCGT
GCTAGTTCCTCATCCA-39, custom sequence as used in Na´ndez
et al. (2014), synthesized by Dharmacon) or nontargeting control
(Dharmacon, siGENOME nontargeting control siRNA2,
D-001210-02, sequence 59-UAAGGCUAUGAAGAGAUAC-39). siRNA
was added to 250 µl OptiMEM, with 8 µl Lipofectamine-3000
(Thermo Fisher Scientific L3000008) mixed with a second
250 µl OptiMEM aliquot. After 5 min, these were combined,
and after 20 min, the siRNA complexes were added to the cells;
200 µl was added to a six-well plate well, 50 µl to a 24-well
plate well. A two-shot protocol was used in which cells were
transfected twice at both 24 and 72 h after seeding, with
analysis (immunolabeling or Western blotting) occurring 24 h
after the second shot.
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Microscopy
Imaging of all FLS experiments and live Xenopus explant samples
were performed on a custom combined spinning disk/total in-
ternal reflection (TIRF) fluorescence microscope supplied by
Cairn research. The system was based on an Eclipse Ti-E in-
verted microscope (Nikon), fitted with an X-Light Nipkow
spinning disk (Core Research for Evolutional Science and
Technology), an iLas2 illuminator (Roper Scientific), a Spectra X
LED illuminator (Lumencor), and a 250-µm piezo-driven
Z-stage/controller (NanoScanZ, Prior). Images were collected
at room temperature through a 100× 1.49 NA oil objective using
a Photometrics Evolve Delta EMCCD camera in 16-bit depth
using Metamorph software (Version 7.8.2.0, Molecular Devices).
Alexa Fluor 488 and GFP samples were visualized using 470/40
excitation and 525/50 emission filters, Alexa Fluor 568 and
mCherry samples with 560/25 excitation and 585/50 emission
filters, and Alexa Fluor 647 samples with 628/40 excitation and
700/75 emission filters. For FLS assays, specific proteins of in-
terest at the FLS tip (at the membrane) were imaged in TIRF
microscopy, in conjunction with a confocal z-stack of the actin
structure. Live time-lapse Xenopus explant samples were imaged
in TIRFM, with images captured every 2 s, at room temperature
in 53 mM NaCl, 32 mM sodium gluconate, 4.5 mM potassium
gluconate, 1 mM CaCl2, 1 mM MgSO4, 5 mM Na2CO3, and Na-
Hepes, to pH 8.3). Cell culture experiments were imaged using a
Zeiss LSM 700 laser scanning confocal microscope driven by
Zeiss ZEN Pro software on a high resolution Axiocam camera
using a Plan-Apochromat 63× 1.40 NA Oil Ph3 M27 objective. All
images were processed in FIJI (ImageJ; Schindelin et al., 2012).
Background-subtracted images of Xenopus explant time-lapse
images were prepared by subtracting the average intensity of
the entire time-course from each individual time point.
Quantification and statistical analysis
Data related to FLS count and FLS physical parameters were
extracted using our Fiji (ImageJ) image analysis plugin FLS Ace,
described in detail in Dobramysl et al. (2019 Preprint). Briefly,
FLS structures are segmented by applying a 2D Difference of
Gaussians filter with subsequent thresholding to each z-slice.
FLS positions are then traced through the stack starting at the
base image by using a greedy algorithm. From this, the FLS
morphology such as length, base area, and straightness are
extracted.
Peptide and protein identification was conducted with the
Proteome Discoverer platform (version 1.4, Thermo Fisher Sci-
entific) using the Mascot search algorithm (version 2.6, Matrix
Science) and searched against a database which combined
Xenbase 9.1 and a database obtained from Wühr et al., (2014)
and https://doi.org/10.17863/CAM.48349 containing 75,603 se-
quence entries, with the Xenopus accession nos. annotated by
comparison to mouse orthologues (Data S1). Fixed modification
of carbamidomethyl and variable modifications of oxidation and
deamidation were selected. Protein grouping was enabled, a
minimum ion score of 20 was required, and a strict parsimony
rule was applied. Trypsin was selected as the enzyme of choice,
and up to two missed cleavages were accepted. Precursor mass
tolerance of 25 ppm and a fragmentmass tolerance of 0.8 Dwere
used. Percolator (version 1.17) validation was applied using a
high-confidence false discovery rate threshold of 0.01 based on q
value. Additional filters included a minimum protein score of 50
and a requirement of two peptides per protein group.
Presence of SNX9 in RPE-1 cell filopodia was scored by
drawing a linescan region of interest over a filopodium and in an
adjacent area with no filopodium in FIJI. The SD in maximal
intensity value of background was calculated, and the numbers
of filopodia with maximal intensity values >1 SD above back-
ground were counted.
Value and number of N, statistical tests used, and what error
bars represent can be found in the figure legends. Statistical
significance of results was defined as *, P < 0.05; **, P < 0.01; and
***, P < 0.001. The two-sample Kolmogorov–Smirnov test used in
Table S1 is a four-way comparison test, with the significance
thresholds divided by four by the Bonferroni correction: *, P <
0.0125; **, P < 0.0025; and ***, P < 0.00025. Graphs were gen-
erated and statistical analysis performed in Prism 8 (Graphpad),
R, or Python (v3.6) using Matplotlib (v2.2.3) and Seaborn
(v0.9.0). FLS data analysis was performed with Pandas (v0.23.4)
and Scipy (v1.1.0) in a Jupyter Lab environment (v0.35.0). The
tSNE plot in Fig. 1 D was generated according to the t-stochastic
neighbor embedding algorithm (van der Maaten and Hinton,
2008) using the tSNE module from the scikit-learn library
(v0.20.3) using six features (the median FLS count with and
without added actin, themedian FLS path lengthwith andwithout
added actin, and themedian FLS base areawith andwithout added
actin) as input after preprocessing them using scikit-learn’s
StandardScaler module. The chosen value for the perplexity pa-
rameter was 2.49, and the value for the early exaggeration pa-
rameter was 12.
Online supplemental material
Fig. S1 shows the FLSAce analysis outputs illustrating the effects
of the addition of each scFv on FLS number and structural pa-
rameters. Fig. S2 shows the immunoprecipitation and mass
spectrometry identification of IgGFls3, Western blots of scFv5
and 21 on extracts, and scFvs3,4,5 and 21 on purified SNX9,
and immunofluorescence of SNX9 at FLS tips. Fig. S3 shows
mNeonGreen-SNX9 at the tips of live Xenopus chordamesoderm
cells, Western blotting illustrating SNX9 siRNA effectiveness
and quantification of SNX9 knockdown on filopodia number in
RPE-1 cells, and immunofluorescence images and quantification
of SNX9 and C. trachomatis presence in filopodia in HeLa cells.
Table S1 shows the statistical analysis of the data presented in
Fig. 2, E and F, for the effects of scFv immunoblock and SNX9
rescue. Table S2 shows the statistical analysis of the data pre-
sented in Fig. 3, C and D, for the effects of wortmannin on FLS
growth. Video 1 shows SNX9 activity at the filopodial tips of live
Xenopus chordamesoderm cells. Data S1 is the database used to
identify proteins following mass spectrometry with Xenopus
accession nos. annotated respective to mouse orthologues.
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Supplemental material
Figure S1. Quantification of FLS phenotypes on antibody addition. Swarmplots showing the output from FLSAce analysis for FLS assays where each
different scFV is preincubated in the reaction mix, specifically illustrating the effects on number, base area (FLS thickness), length (path length) and
straightness of each scFV. Colors match the colors of scFvs in Fig. 1. Data points represent mean values of FLS within an individual imaging region (n = 10–17
regions per condition). Black lines indicate the median with its 95% confidence interval. Data are from three independent experiments for each scFv containing
no additional actin (A, C, E, and G) and two experiments where 1 µM of supplemental unlabeled actin was added (B, D, F, and H). The addition of unlabeled actin
makes FLS longer, thus increasing the length over which morphologies, such as curliness, can be seen. Additional actin also means that the phenotype of
antibodies that lead to longer FLS (perhaps by inhibiting depolymerization processes) is less limited by the concentration of actin and conversely, endogenous
concentrations of actin (i.e., the no additional actin condition) can make phenotypes of shorter or fewer FLS more obvious.
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Figure S2. SNX9 is the antigen to scFvs 3, 4, 5, and 21. (A) Extracts, control, and IgGFLS3 immunoprecipitation. (B) Venn diagram of mass spectrometry
identification from the gel sectors indicated in A. (C) SNX9 gives the highest protein score and number of unique peptides. (D)Western blot of purified SNAP-
SNX9 (left lane = 121 nM, right = 302.5 nM) with scFvs 3 and 4. (E) Western blot of Xenopus egg extracts and purified SNX9 for scFv5 and 21, which detect a
specific ∼70 kD band (red arrow), though scFv21 does not detect purified SNX9. (F) TIRF and confocal imaging of FLS immunolabeled using a rabbit anti-SNX9
polyclonal antibody illustrating SNX9 (green) localized at FLS tips as marked by actin (magenta; TIRF in isolated channel, maximal projection of a 1 µm z-stack
in merged image). Scale bar, 10 µm.
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Figure S3. SNX9 in cells. (A) Single frame from a TIRFM time-lapse of Xenopus chordamesoderm cells expressing mNeonGreen-SNX9 (green) and GAP-RFP
membrane marker (magenta) showing SNX9 at the tip of filopodia. Scale bar, 10 µm. (B)Western blots against SNX9 or the loading control DM1α (tubulin) of
untreated RPE-1 cells and cells treated with either non-targeting control (Non-targ.) or anti SNX9 siRNA showing knockdown with the SNX9 siRNA sequence.
(C) Quantification of the number of filopodia present per cell in untreated RPE-1 cells and cells treated with either nontargeting control or anti SNX9 siRNA,
illustrating no change in the average number of filopodia per cell on SNX9 knockdown. Each data point represents an individual cell; n = 18, 13, and 23 cells for
the untreated (unt.), non-targeting control (NT Cont.), and SNX9 siRNA–treated conditions, respectively. Lines indicate mean ± SD. Statistical significance was
assessed by Kruskal-Wallis ANOVA with Dunn’s multiple comparisons test. Overall ANOVA P = 0.1206 (n.s.), multiple comparisons: untreated vs. nontargeting
control P = 0.1481 (n.s.), untreated vs. SNX9 siRNA P > 0.9999 (n.s.), nontargeting control vs. SNX9 siRNA P = 0.2800 (n.s.). (D and E) Example images of
fluorescence confocal images of HeLa cells either (D) uninfected or (E) infected with C. trachomatis (yellow) and immunolabeled using mouse anti-human SNX9
(purple) and phalloidin (green), illustrating SNX9 presence in filopodia and how C. trachomatis stick to preexisting filopodia that contain SNX9 in either the tip or
shaft of the filopodia. Scale bars, 2 µm. (F) Quantification of SNX9 presence in filopodia in both uninfected HeLa cells and in cells infected with C. trachomatis.
SNX9 immunolabeling stains ∼95% of filopodia in untreated RPE-1 with no difference on C. trachomatis infection. Each data point represents an individual
imaging region; n = 20 regions per condition. Lines indicate mean ± SD. Infected: 2,080 filopodia from 97 cells; uninfected: 1,648 filopodia from 126 cells.
Statistical significance was assessed by unpaired t test, P = 0.3239 (n.s.).
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Video 1. SNX9 is active at filopodial tips in Xenopus dorsal marginal zone explants. TIRFM time-lapse of Xenopus chordamesoderm cells expressing
mNeonGreen-SNX9 (green) and GAP-RFP (magenta) showing active filopodia with SNX9 at their tips. Frames were captured every 2 s and are replayed at 15
fps. Scale bar, 10 µm.
Tables S1 and S2 are provided online. Table S1 shows statistics for effect of immunoblock and addition of SNX9 on FLS.
Quantification of the data shown in Fig. 2, E and F. Analysis uses a two-sample Kolmogorov–Smirnov test with Bonferroni
correction for multiple comparisons. Imaging regions per condition: control immunoblock n = 10, control rescue n = 11, scFv3
immunoblock n = 10, scFv3 rescue n = 9, scFv4 immunoblock n = 9, scFv4 rescue n = 12, scFv5 immunoblock n = 12, scFv5 rescue n =
11, scFv21 immunoblock n = 12, scFv21 rescue n = 10. Table S2 shows statistics for effect of Wortmannin on FLS grown on different
lipid compositions. Quantification of data in Fig. 3, C and D. Statistical significance for both FLS path length and FLS count (>3 µm)
was assessed by ordinary one-way ANOVAwith Holm-Sidak’s multiple comparisons test. Overall ANOVA for both path length (Fig. 3
C) and FLS count (Fig. 3 D), ****, P < 0.0001. Significance for individual comparisons are shown in the table. n = 24 imaging regions
for each treatment.
A supplemental dataset is also provided online that shows X. laevis proteome with Mus musculus orthologues.
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